It has been previously shown that the transcription factor FOXD3 is rapidly induced in melanoma cells upon inhibition of MAPK signalling and that this phenomenon contributes to adaptive resistance to RAF inhibitors also in part through enhanced transcription of the ErbB3 receptor gene [22]. This evidence concerns the gene FOXD3 and melanoma.